BERLIN/FRANKFURT, March 1 The DAX top-30 index
looked set to open 0.6 percent higher on Wednesday,
according to premarket data from brokerage Lang & Schwarz at
The following are some of the factors that may move German
President Donald Trump told Congress on Tuesday he was open
to immigration reform, shifting from his harsh rhetoric on
illegal immigration in a speech that offered a more restrained
tone than his election campaign and first month in the White
House. In a prime-time address to a country that remains divided
over his leadership, he emphasixed his desire to focus on
problems at home by boosting the U.S. economy with tax reform, a
$1 trillion infrastructure effort and an overhaul of President
Barack Obama's signature healthcare law, known as Obamacare.
Bayer indicated up 1 pct
Bayer said it still expected a mid-single-digit percentage
increase in core earnings per share from continuing operations
in 2017 after reducing its holding in Covestro to 53.3 percent
from 64.2 percent through the placement of shares at 66.50 euros
Indicated up 0.6 pct
Rival Pfizer was warned by the U.S. Food and Drug
Administration that its process for manufacturing sterile
injectable drugs at a plant in Kansas was "out of control" and
put patients at risk - a development that could benefit
Fresenius's Kabi unit.
Indicated up 1.6 pct
Rheinmetall reported a better-than-expected 23 percent
year-on-year jump in 2016 operating profit, driven by its
Indicated up 0.4 pct
Stada swung to a net loss in the fourth quarter and said it
would raise its dividend 3 percent to 0.72 euros per share. It
said it expected adjusted sales of 2.28 to 2.35 billion euros
this year and adjusted net income between 195 and 205 million
Indicated down 3.9 pct
Zalando said it would invest heavily in 2017 and create more
than 2,000 jobs, as it announced its first move into physical
stores with the acquisition of basketball retailer Kickz.
Indicated up 3.9 pct
Operating earnings (EBITDA) for 2016 rose 57 percent to 285
million euros, translating into a margin of 8.4 percent, which
Nordex said was slightly above guidance. The company slashed its
2017 guidance last week, citing weaker expectations for business
in Brazil, India and South Africa.
Indicated up 3.2 pct
Biotest said it would launch recombinant clotting factor
VIII with the name Vihuma in Germany in April.
Indicated up 1.1 pct
Capital Stage said it was confident of achieving its
earnings targets for 2016 and expected growth to continue in
KLOECKNER & CO
Indicated up 2.7 pct
Operating earnings (EBITDA) for 2016 rose to a five-year
high of 196 million euros and proposed a dividend of 0.20 euros
per share. It forecast further growth in operating income for
2017 and said higher steel prices at the beginning of the year
should lead to "very substantial" growth in Q1 with EBITDA
between 65 and 75 million euros.
No indication available
Zeal reported 2016 normalised EBIT up 8 percent to 51
TALANX - Deutsche Bank cuts to "hold" from "buy"
CAPITAL STAGE - Berenberg starts with "buy"
OVERSEAS STOCK MARKETS
Dow Jones -0.1 pct, S&P 500 -0.3 pct, Nasdaq
-0.6 pct at close.
Nikkei +1.4 pct, Shanghai stocks +0.2 pct.
Time: 7.40 GMT.
GERMAN ECONOMIC DATA
German February Markit manufacturing PMI due at 0855 GMT.
Seen unchanged at 57.0 points.
German February jobless figures due at 0900 GMT. Seen
-10,000 seasonally adjusted, unemployment rate seen unchanged at
German February inflation data due at 1300 GMT. CPI and HICP
both seen +0.6 pct m/m, +2.1 pct y/y.
EUROPEAN FACTORS TO WATCH
REUTERS TOP NEWS
($1 = 0.9441 euros)
(Reporting by Emma Thomasson and Georgina Prodhan)